Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized placebo-controlled study of dextrin-2 sulphate vaginal gel in sexually active women and male partners at low HIV risk
ISRCTN92729667Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Dec 1998
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
01
Overview
Phase 2, randomised, double-blind trial of dextrin 2-sulfate in human immunodeficiency virus infection (HIV), sponsored by Medical Research Council. Primary endpoints: Genital epithelium disruption and Systemic absorption. Started Dec 1998; status: completed.
02
Drugs
dextrin 2-sulfate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN92729667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN92729667.